Digital therapeutics company specializing in prescription digital therapeutics (PDTs)
Pear Therapeutics going public via SPAC merger valued at $1.6B
Pear Therapeutics going public via SPAC merger valued at $1.6B
Pear Therapeutics licensed technology from multiple digital health startups
Pear Therapeutics going public via SPAC valued at $1.6B
No published content mentioning Pear Therapeutics yet